Skip to main content
Log in

Kit-like 18F-labeling of an estradiol derivative as a potential PET imaging agent for estrogen receptor-positive breast cancer

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

16α-18F-fluoroestradiol (18F-FES) has been developed as a promising positron emission tomography (PET) imaging agent for targeting estrogen receptor positive (ER+) breast cancer in the clinical trial. However, the radiosynthesis of 18F-FES often requires two steps and tough experimental conditions. Therefore, a new estradiol derivative (18F-AmBF3-ES) was prepared by an efficient one-step 18F-radiolabeling method. The tracer was obtained in high yield (~65%) and excellent radiochemical purity (>98%) within 30 min. The uptake rate of 18F-AmBF3-ES in ER+ cells was about 3.5% at 30 min. The results suggested that the tracer may be a potential PET imaging agent for ER+ breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Scheme 1
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87–108

    Article  Google Scholar 

  2. Linden HM, Dehdashti F (2013) Novel methods and tracers for breast cancer imaging. Semin Nucl Med 43:324–329

    Article  Google Scholar 

  3. Harvey JM, Clark GM, Osborne CK, Allred DC (1999) Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 17:1474–1481

    Article  CAS  Google Scholar 

  4. Fowler AM, Chan SR, Sharp TL, Fettig NM, Zhou D, Dence CS, Carlson KE, Jeyakumar M, Katzenellenbogen JA, Schreiber RD, Welch MJ (2012) Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer. J Nucl Med 53:1119–1126

    Article  CAS  Google Scholar 

  5. Zhou D, Lin M, Yasui N, Al-Qahtani MH, Dence CS, Schwarz S, Katzenellenbogen JA (2014) Optimization of the preparation of fluorine-18-labeled steroid receptor ligands 16alpha-[18F]fluoroestradiol (FES), [18F]fluoro furanyl norprogesterone (FFNP), and 16beta-[18F]fluoro-5alpha-dihydrotestosterone (FDHT) as radiopharmaceuticals. J Label Compd Radiopharm 57:371–377

    Article  CAS  Google Scholar 

  6. Katzenellenbogen JA (1995) Designing steroid receptor-based radiotracers to image breast and prostate tumors. J Nucl Med 36(suppl 6):8S–13S

    CAS  Google Scholar 

  7. Enginar H, Ünak P, Yurt F, Biber FZ (2002) An oestrogen-derivative labeled with 99mTc and its radiopharmaceutical potential. J Radioanal Nucl Chem 251:473–479

    Article  CAS  Google Scholar 

  8. Biber FZ, Unak P, Enginar H, Ertay T, Medine EI, Tasci C, Durak H (2005) Synthesis of DTPA-attached estradiol derivative and determination of its radiopharmaceutical potential. J Radioanal Nucl Chem 266:445–454

    Article  CAS  Google Scholar 

  9. Xia X, Feng H, Li C, Qin C, Song Y, Zhang Y, Lan X (2016) 99mTc-labeled estradiol as an estrogen receptor probe: preparation and preclinical evaluation. Nucl Med Biol 43:89–96

    Article  CAS  Google Scholar 

  10. Brodack JW, Kilbourn MR, Welch MJ (1988) Automated production of several positron-emittingradiopharmaceuticals using a single laboratory robot. Appl Radiat Isot 39:689–698

    Article  CAS  Google Scholar 

  11. Linden HM, Stekhova SA, Link JM, Gralow JR, Livingston RB, Ellis GK, Petra PH, Peterson LM, Schubert EK, Dunnwald LK, Krohn KA, Mankoff DA (2006) Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer. J Clin Oncol 24:2793–2799

    Article  CAS  Google Scholar 

  12. Mortimer JE, Dehdashti F, Siegel BA, Katzenellenbogen JA, Fracasso P, Welch MJ (1996) Positron emission tomography with 2-[18F]fluoro-2-deoxy-Dglucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy. Clin Cancer Res 2:933–939

    CAS  Google Scholar 

  13. McGuire AH, Dehdashti F, Siegel BA, Lyss AP, Brodack JW, Mathias CJ, Mintun MA, Katzenellenbogen JA, Welch MJ (1991) Positron tomographic assessment of 16α-[18F]Fluoro-17/3-estradiol uptake in metastatic breast carcinoma. J Nucl Med 32:1526–1531

    CAS  Google Scholar 

  14. Oude Munnink TH, Nagengast WB, Brouwers AH, Schroder CP, Hospers GA, Lub-de Hooge MN, van der Wall E, van Diest PJ, de Vries EG (2009) Molecular imaging of breast cancer. Breast 18(suppl 3):S66–S73

    Article  Google Scholar 

  15. Kiesewetter DO, Kilbourn MR, Landvatter SW, Heiman DF, Katzenellenbogen JA, Welch MJ (1984) Preparation of four fluorine-18-labeled estrogensand their selective uptakes in target tissues of immature rat. J Nucl Med 25:1212–1221

    CAS  Google Scholar 

  16. Brodack JW, Kilbourn MR, Welch MJ, Katzenellenbogen JA (1986) Application of robotics to radiopharmaceutical preparation: controlled synthesis of fluorine-18 16α-fluoroestradiol-17β. J Nucl Med 27:714–721

    CAS  Google Scholar 

  17. Mintun MA, Welch MJ, Siegel BA, Mathias CJ, Brodack JW, McGuire AH, Katzenellenbogen JA (1988) Breast cancer PET imaging of estrogen receptors. Radiology 169:45–48

    Article  CAS  Google Scholar 

  18. Romer J, Fuchtner F, Steinbach J, Johannsen B (1999) Automated production of 16α-[18F]Fluoroestradiol for breast cancer imaging. Nucl Med Biol 26:473–479

    Article  CAS  Google Scholar 

  19. Knott KE, Grätz D, Hübner S, Jüttler S, Zankl C, Müller M (2011) Simplified and automatic one-pot synthesis of 16α-[18F]fluoroestradiol without high-performance liquid chromatography purification. J Label Compd Radiopharm 54:749–753

    Article  CAS  Google Scholar 

  20. Oh SJ, Chi DY, Mosdzianowski C, Kil HS, Ryu JS, Moon DH (2007) The automatic production of 16alpha-[18F]fluoroestradiol using a conventional [18F]FDG module with a disposable cassette system. Appl Radiat Isot 65:676–681

    Article  CAS  Google Scholar 

  21. Kil HS, Cho HY, Lee SJ, Oh SJ, Chi DY (2013) Alternative synthesis for the preparation of 16alpha-[(18) F]fluoroestradiol. J Label Compd Radiopharm 56:619–626

    Article  CAS  Google Scholar 

  22. Liu Z, Lin KS, Benard F, Pourghiasian M, Kiesewetter DO, Perrin DM, Chen X (2015) One-step (18)F labeling of biomolecules using organotrifluoroborates. Nat Protoc 10:1423–1432

    Article  CAS  Google Scholar 

  23. Liu Z, Pourghiasian M, Radtke MA, Lau J, Pan J, Dias GM, Yapp D, Lin KS, Benard F, Perrin DM (2014) An organotrifluoroborate for broadly applicable one-step 18F-labeling. Angew Chem Int Ed Engl 53:11876–11880

    Article  CAS  Google Scholar 

  24. Pourghiasian M, Liu Z, Pan J, Zhang Z, Colpo N, Lin KS, Perrin DM, Benard F (2015) (18)F-AmBF3-MJ9: a novel radiofluorinated bombesin derivative for prostate cancer imaging. Bioorg Med Chem 23:1500–1506

    Article  CAS  Google Scholar 

  25. Liu Z, Pourghiasian M, Benard F, Pan J, Lin KS, Perrin DM (2014) Preclinical evaluation of a high-affinity 18F-trifluoroborate octreotate derivative for somatostatin receptor imaging. J Nucl Med 55:1499–1505

    Article  CAS  Google Scholar 

  26. Liu Z, Radtke MA, Wong MQ, Lin KS, Yapp DT, Perrin DM (2014) Dual mode fluorescent (18)F-PET tracers: efficient modular synthesis of rhodamine-[cRGD]2-[(18)F]-organotrifluoroborate, rapid, and high yielding one-step (18)F-labeling at high specific activity, and correlated in vivo PET imaging and ex vivo fluorescence. Bioconjug Chem 25:1951–1962

    Article  CAS  Google Scholar 

  27. Aucagne V, Valverde IE, Marceau P, Galibert M, Dendane N, Delmas AF (2012) Towards the simplification of protein synthesis: iterative solid-supported ligations with concomitant purifications. Angew Chem Int Ed Engl 51:11320–11324

    Article  CAS  Google Scholar 

  28. Li H, Aneja R, Chaiken I (2013) Click chemistry in peptide-based drug design. Molecules 18:9797–9817

    Article  CAS  Google Scholar 

  29. Zhu C, Xu Q, Pan D, Xu Y, Liu P, Yang R, Wang L, Sun X, Luo S, Yang M (2016) Prostate cancer imaging of FSHR antagonist modified with a hydrophilic linker. Contrast Media Mol Imaging 11:99–105

    Article  CAS  Google Scholar 

  30. Leeson PD, Springthorpe B (2007) The influence of drug-like concepts on decision-making in medicinal chemistry. Nat Rev Drug Discov 6:881–890

    Article  CAS  Google Scholar 

  31. Leo AH, Hansch C, Elkins D (1971) Partition coefficients and their uses. Chem Rev 71(6):525–616

    Article  CAS  Google Scholar 

  32. Sukerkar PA, MacRenaris KW, Meade TJ, Burdette JE (2011) A steroid-conjugated magnetic resonance probe enhances contrast in progesterone receptor expressing organs and tumors in vivo. Mol Pharm 8:1390–1400

    Article  CAS  Google Scholar 

  33. Liu Y, Miao Q, Zou P, Liu L, Wang X, An L, Zhang X, Qian X, Luo S, Liang G (2015) Enzyme-controlled intracellular self-assembly of (18)F nanoparticles for enhanced MicroPET imaging of tumor. Theranostics 5:1058–1067

    Article  CAS  Google Scholar 

  34. Huang R, Wang X, Wang D, Liu F, Mei B, Tang A, Jiang J, Liang G (2013) Multifunctional fluorescent probe for sequential detections of glutathione and caspase-3 in vitro and in cells. Anal Chem 85:6203–6207

    Article  CAS  Google Scholar 

  35. Aliaga A, Rousseau JA, Ouellette R, Cadorette J, van Lier JE, Lecomte R, Benard F (2004) Breast cancer models to study the expression of estrogen receptors with small animal PET imaging. Nucl Med Biol 31:761–770

    Article  CAS  Google Scholar 

  36. Okamoto M, Naka K, Kitagawa Y, Ishiwata K, Yoshimoto M, Shimizu I, Toyohara J (2015) Synthesis and evaluation of 7alpha-(3-[(18)F]fluoropropyl) estradiol. Nucl Med Biol 42:590–597

    Article  CAS  Google Scholar 

  37. Qin C, Lan X, He J, Xia X, Tian Y, Pei Z, Zhang Y (2013) An in vitro and in vivo evaluation of a reporter gene/probe system hERL/18F-FES. Plos One 8:e61911

Download references

Acknowledgements

This work was financially supported by Natural Science Foundation of China (21371082), Natural Science Foundation of Jiangsu Province (BK20141102 and BK20151118) and Key Medical Talent Project of Jiangsu Province (RC2011097).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jianguo Lin or Ling Qiu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, G., Wang, W., Lin, J. et al. Kit-like 18F-labeling of an estradiol derivative as a potential PET imaging agent for estrogen receptor-positive breast cancer. J Radioanal Nucl Chem 312, 599–607 (2017). https://doi.org/10.1007/s10967-017-5245-7

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10967-017-5245-7

Keywords

Navigation